A Highly Conserved Peptide Vaccine Candidate Activates Both Humoral and Cellular Immunity Against SARS-CoV-2 Variant Strains

Facing the imminent need for vaccine candidates with cross-protection against globally circulating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mutants, we present a conserved antigenic peptide RBD9.1 with both T-cell and B-cell epitopes. RBD9.1 can be recognized by coronavirus disea...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Fengxia, Huang, Jingjing, Li, Tingting, Hu, Chao, Shen, Meiying, Mu, Song, Luo, Feiyang, Song, Shuyi, Hao, Yanan, Wang, Wang, Han, Xiaojian, Qian, Chen, Wang, Yingming, Wu, Ruixin, Li, Luo, Li, Shenglong, Jin, Aishun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8688401/
https://www.ncbi.nlm.nih.gov/pubmed/34950151
http://dx.doi.org/10.3389/fimmu.2021.789905

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8688401/
https://www.ncbi.nlm.nih.gov/pubmed/34950151
http://dx.doi.org/10.3389/fimmu.2021.789905

Ejemplares similares